<- Go home

Added to YB: 2024-07-25

Pitch date: 2024-07-25

EGRX [bullish]

Eagle Pharmaceuticals, Inc.

-84.78%

current return

Author Info

No bio for this author

Company Info

Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on manufacturing, developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States.

Market Cap

$12.6M

Pitch Price

$5.78

Price Target

N/A

Dividend

N/A

EV/EBITDA

N/A

P/E

1.06

EV/Sales

N/A

Sector

Biotechnology

Category

N/A

Show full summary:
EAGLE PHARMACEUTICALS INC EGRX

A summary for this pitch has not been created yet.

Read full article (0 min)